Buyer Briefing
4 min read · 750 words
An FDA **Notice of Detention and Hearing** means a U.S. beverage entry appears to violate a requirement. It is not yet the same as a final refusal. The importer, owner or consignee should read the exact entry lines, alleged charges, response deadline and FDA contact before choosing between documented testimony and a proposed correction. Neither path guarantees release.
- Read actual charges and response deadline|Separate documentation from correctable violations|Obtain FDA approval before any reconditioning|Track final line-specific disposition
An FDA Notice of Detention and Hearing means a U.S. beverage entry appears to violate a requirement. It is not yet the same as a final refusal. The importer, owner or consignee should read the exact entry lines, alleged charges, response deadline and FDA contact before choosing between documented testimony and a proposed correction. Neither path guarantees release. FDA detention guidance.
Read the notice and response deadline
The U.S. Food and Drug Administration (FDA) issues a Notice of FDA Action marked Detained when an imported article appears non-compliant. The notice identifies the affected entry lines, cited grounds, compliance officer and respond-by date. That date, not a generic online estimate, should govern the immediate action plan.
The owner or consignee may present oral or written testimony under 21 CFR § 1.94. FDA guidance also recognises the importer of record or a duly authorised representative as a possible respondent. Confirm who can speak for the entry and have the customs broker provide the notice and line-level status.
Ask the named compliance officer for an extension before the deadline if evidence cannot be assembled in time. FDA may grant or deny the request. The cargo should not be distributed on the assumption that detention will be lifted. Coordinate any location change or examination with FDA and U.S. Customs and Border Protection (CBP). FDA detention guidance.
Separate the alleged violation from missing evidence
A detention is based on an appearance of a violation, such as suspected adulteration or misbranding. The importer first needs to understand whether the allegation can be challenged by existing records or calls for a proposed correction. FDA's final decision concerns admissibility, not merely whether documents were uploaded. 21 U.S.C. § 381(a).
| Notice finding | Evidence or decision to prepare | Responsible party |
|---|---|---|
| Question about product identity or shipment records | Entry line, invoice, lot and product identification, label version | Importer with broker and supplier |
| Apparent labeling violation | Actual U.S.-market label, ingredients, pack images and explanation | Importer with label specialist |
| Apparent safety or contamination issue | Relevant test method, lot scope, supporting technical records | Importer with qualified laboratory or technical adviser |
| Potentially correctable defect | Written proposal explaining corrective work and controls | Eligible applicant, subject to FDA authorisation |
A private laboratory report can help in some detention cases, but FDA evaluates its adequacy and the applicable violation. Upload entry-specific evidence through the Import Trade Auxiliary Communication System (ITACS) or use the compliance officer's specified route. Do not substitute an unrelated SKU's certificate or assume a commercial quality certificate resolves an FDA charge.
Evaluate authorised reconditioning options
When evidence alone cannot overcome the alleged defect, the appropriate party may ask FDA to authorise relabeling or reconditioning. FDA explains that the importer of record ordinarily submits Form FDA 766 to the compliance officer. The regulation at 21 CFR § 1.95 specifies the owner or consignee as the applicant, so the parties should align applicant authority with the actual entry and FDA's instructions.
A proposal must describe the intended corrective work, where it will occur and the approximate completion period. For relabeling, include the proposed replacement artwork. Filing the form is a request, not permission to start work. Under 21 CFR § 1.96, FDA's written authorisation may impose supervision, time limits and other controls. FDA can deny a plan that does not establish a credible route to compliance. FDA reconditioning guidance.
An importer should not independently open, over-sticker or repack detained beverage inventory based solely on a broker's suggestion. Confirm the written FDA decision, identify affected lots and arrange approved operations only within its terms. Following permitted work, FDA may examine the product at the importer's expense. A successful correction may result in release, but a failed one may result in refusal. FDA reconditioning guidance.
Record release, refusal or the next required action
Keep a single entry decision record: notice version and date, charged provisions, affected quantities and lots, response due date, FDA correspondence, evidence submitted, proposed work, permissions, inspection outcome and the final Notice of FDA Action.
The result may be a release, continued review, partial release with partial refusal, or refusal. FDA explains that refused merchandise generally must be exported or destroyed under CBP/FDA supervision within 90 days after refusal. This is not the detention response period. Do not mark stock as market-ready until the relevant entry lines are actually released. FDA refusal guidance.
If a beverage buyer needs supporting product, label or lot information, contact VINUT about available documentation for the selected shipment. The U.S. importer and responsible professionals should handle FDA responses and entry-specific decisions.
FAQ
Does an FDA detention notice mean the beverage shipment has already been refused?
No. A Detained notice identifies an apparent violation and provides an opportunity for testimony. FDA may subsequently release or refuse the affected entry lines. See [FDA detention guidance](https://www.fda.gov/industry/fda-import-process/detention-hearing).
Can an importer relabel drinks immediately after filing Form FDA 766?
No. FDA may grant or deny a reconditioning proposal. The proposed operations should proceed only after the applicable written authorisation and under its conditions. See [21 CFR § 1.96](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-1/subpart-E/section-1.96).
Does the 90-day export or destruction period run from the detention notice?
No. FDA's refusal guidance describes 90 days from the **refusal** notice. The earlier detention notice has its own stated respond-by date. See [FDA import refusals](https://www.fda.gov/industry/fda-import-process/import-refusals).
Regulatory information
- Markets
- US
- Product groups
- Juice, Coconut water, Other beverage
- Detention & Hearing: notice, testimony, response deadline and eligible actors
U.S. Food and Drug Administration · FDA Import Process — Detention & Hearing
- Reconditioning of Imported FDA-Regulated Products: Form FDA 766 and FDA permission
U.S. Food and Drug Administration · FDA Import Process — Reconditioning
- 21 USC § 381 — imports, detention testimony, refusal and reconditioning
Office of the Law Revision Counsel, U.S. House of Representatives · 21 U.S.C. §381(a)-(b), OLRC section text in effect through Pub. L. 119-142 (2026-11-10), 119th Congress 2nd-session classification table through PL119-142 (2026-11-10); post-Nov10 currentness unverified
- Hearing on refusal of admission or destruction
Electronic Code of Federal Regulations (U.S. OFR) · 21 CFR 1.94
- Application for authorization to relabel and recondition
Electronic Code of Federal Regulations (U.S. OFR) · 21 CFR 1.95
- Granting of authorization to relabel and recondition
Electronic Code of Federal Regulations (U.S. OFR) · 21 CFR 1.96
- Import Refusals: decisions, shipment disposition and 90-day deadline
U.S. Food and Drug Administration · FDA Import Process — Import Refusals
Regulatory information is provided for trade reference. Confirm current requirements with the relevant authorities before making market decisions.
About this article

The VINUT editorial team publishes articles about beverage ingredients, product characteristics, and practical information for readers and international buyers.
